Background: ISO 9001 and ISO 15189 have been established as continuative models for quality systems beyond national laws, mandatory standards and guidelines of expert associations regarding analytical and organisational performance of medical laboratories and transfusion services. Although widely used, their impact on laboratory performance has not been investigated. Methods: We retrospectively analysed the results of 167 laboratories in 59 distributions of the Austrian red cell immunohaematology external quality assessment (EQA) scheme in the years 1999-2017. The performance for each parameter and trends of individual participants were compared with respect to certification or accreditation status of participants' quality systems and to laboratory type. Results: Considering more than 52,000 EQA results, the absence or presence of a laboratory quality management system showed different error rates. Laboratories with ISO
Introduction
National and international laws, standards and guidelines of expert associations regulate or recommend quality assurance measures in medical laboratories and amongst others require participation in external quality assessment (EQA) programmes. In the last decades, frameworks giving in-depth specifications for quality systems have been developed by the International Organization for Standardization (ISO) at a global scale. In medical laboratories and transfusion services, International Standards ISO 9001 "Quality management systems -Requirements" and ISO 15189 "Medical laboratories -Requirements for quality and competence" are most commonly applied [1, 2] . A certificate of conformity of a quality system with the requirements of ISO 9001 is provided by independent auditing organisations after an audit, which is a "systematic, independent and documented process for obtaining objective evidence and evaluating it objectively to determine the extent to which the audit criteria are fulfiled", and "audit criteria" are the requirements of ISO 9001 [1] . Accreditation (ISO 15189) is defined as "procedure by which an authoritative body gives formal recognition that a body or person is competent to carry out specific tasks" [3] . Both standards have been evaluated for practical use in laboratories and transfusion services and suitability for such institutions has been declared [4] [5] [6] [7] . In terms of factors that affect the quality performance of a laboratory, these standards are more detailed than regulatory requirements, like the Austrian Federal Act on Hospitals and Nursing Institutes for hospital laboratories and hospital transfusion services and the Austrian Law on Doctors for independent laboratories, the Austrian Standard K 1950 "Quality Assurance in medical laboratories" and the ÖGBT-Standards "Immunohaematology examinations in patients" [8] [9] [10] [11] : -Measures for training and competence management of employees -Recurrent qualification of test systems and technical equipment -Not only initiation of corrective and preventive actions, but also the later review of the effectiveness of the actions taken is required -Internal audits to verify the functionality of the quality system -Periodic reviews by laboratory top management include the assessment of quality indicators -And last but not least, periodic external audits by certification companies or accreditation bodies guarantee a view from external quality management experts to the procedures These specific requirements may have contributed to raising expectations of improving the performance of laboratories through the use of such quality systems, so that by the end of 2016, 6939 institutions have been accredited according to ISO 15189 worldwide (data provided by the International Laboratory Accreditation Cooperation Secretariat, Jan 23 2018), and 24,320 institutions have been certified worldwide according to ISO 9001 within the European Accreditation Code 38, health, veterinary and social work [12] . But implementation of ISO 9001 and ISO 15189 quality systems is a huge effort and requires financial and personnel resources [13] . It is therefore notable that, in times of increasing economic pressure and a trend towards evidence-based medicine, robust and high-quality data on the impact of introducing of such standards on quality indicators for laboratory services has not yet been published [14] . A key quality indicator to assess and compare the performance of laboratories is the error rate, including incorrect EQA results [15] . In EQA schemes, participants test samples of known, but undisclosed, content and submit the result to the EQA provider, which assesses the results according to a method described in the International Standard ISO 13528 "Statistical methods for use in proficiency testing by interlaboratory comparison" and provides objective feedback to the participants [16] . Of course, improvement in laboratory performance only by participation in EQA schemes is not to be expected, but such schemes can indicate problems in laboratory procedures or methods, and it remains to the laboratory management to take appropriate measures after receiving incorrect EQA results [17, 18] .
The aims of this study were to compare the analytical performance of laboratories with or without ISO 9001 certification and ISO 15189 accreditation and to investigate whether the analytical performance changed after an individual laboratory obtained certification or accreditation. Incorrect EQA results were chosen as a measure of the analytical performance.
Materials and methods
An immunohaematology EQA scheme was chosen for these examinations as the nominal results can be clearly assessed to be correct or incorrect, the measurement procedures vary only marginally, and commutability plays no role, because sample material can be used in the same way for all test systems and same results are expected [19] . In the red cell immunohaematology EQA scheme of ÖQUASTA (Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests), blood group serology determinations for pretransfusion testing are performed. Participants receive two suspensions of human erythrocytes and two samples of human serum that possibly contain irregular antibodies. Sample pairs are either obtained from one donor each, or suitable constellations of antigens and antibodies are prepared. Samples were produced by DiaMed AG, Cressier, Switzerland, or Antitoxin GmbH, Bammental, Germany, in accordance with ISO Guide 35 "Reference materialsGeneral and statistical principles for certification" [20] . The task in this EQA scheme is to identify ABO blood group, Rh (Rhesus), and Kell phenotype of erythrocytes, and perform a direct antiglobulin test (DAT) with those cells; screening for irregular antibodies is to be performed in serum samples, and -in case this is positive -the irregular antibody or antibodies shall be identified. Two further erythrocyte samples are provided to perform a cross-match with serum samples. Participants were instructed to carry out the examinations of EQA samples in the same way as routine examinations and to submit the results either electronically via the web portal or by fax. The immunohaematology EQA scheme of ÖQUASTA included three distributions a year until 2015 and four after 2015. According to Chapter 7.6 of ISO 13528:2015, the correctness of results submitted by participants was assessed by comparison to targets obtained in an expert laboratory [16] . This evaluation is carried out by a software tool that compares each individual result with the target assigned to the specific sample and assesses it as correct or incorrect. Due to the small methodological differences of the individual test procedures and the exclusively qualitative (positive/negative) results, results of participants are not grouped according to test systems used. Results of all participants are summarised in a general report and participants' performance is further assessed in an individual report.
We collected red cell immunohaematology EQA results that were submitted in the period 1999-2017 by a total of 182 laboratories, of which 78 laboratories regularly participated, 60 began participation, 31 terminated participation and 13 laboratories began participation after and finished participation before the beginning and end of the observation time. Participants included 112 hospital laboratories, 44 independent laboratories and 26 transfusion services. On average, 140 laboratories participated in each distribution. Each result submitted by the participants was individually evaluated for its correctness. Laboratories reported the result according to the level of detail that they report as routine. A result that matched the target value to the level of detail that was reported was considered as correct. Each incorrect result was screened for possible sample swap, which was defined as a pair of results in which the incorrect result reported for sample 1 would have been correct for sample 2 and vice versa. Incorrect results were not corrected when participants reported data entry or submission errors after receiving their individual reports.
The effectiveness of the use of quality systems was investigated in two ways. The rates of incorrect results obtained with or without a certified or accredited quality system were compared for each parameter separately. For this purpose, every reported result was evaluated for its correctness on the one hand, and the certification/accreditation status under which it was obtained on the other hand. For evaluating the effectiveness of implementation of a quality system according to ISO 9001 or ISO 15189 standards, the rates of incorrect results of 38 laboratories that underwent certification/accreditation during the observation period before and after certification to ISO 9001 or accreditation according to ISO 15189 were compared for each parameter separately.
Statistical analysis was performed using a generalised estimating equations for binomial data, taking into account the fact that results were clustered per laboratory [21] . Results are provided by means of odds ratios, which in comparison of two groups reflect the odds of producing a wrong result in the firstly mentioned group with respect to the odds of a wrong result in the secondly mentioned group. They are based on the frequencies of correct and incorrect results in relation to the total number of results. p-Values test the hypothesis that odds ratios are equal to 1. When p-values are smaller than 0.05, it is decided that the odds of producing a wrong result is different between the compared groups.
The conducted research is not related to either human or animals' use.
Results
Of all 182 participants, three laboratories did not report their quality system status; during the observation period, 91 laboratories had no ISO quality system; 38 laboratories had quality systems according to ISO 9001 during the entire observation period and 38 laboratories established such quality systems during the observation time; 12 laboratories had quality systems according to ISO 9001 but did not provide information about their certification date. During the observation period, five laboratories were accredited according to ISO 15189; three of those had ISO 9001 since the beginning, one obtained it during the observation period and one did not provide information about earlier ISO 9001 certification.
A total of 56,676 results were submitted by 182 participants. After excluding the results from 15 participants that could not be assigned to a quality system status for evaluation 52,138 results remained. Of all the evaluated results, 604 (1.1%) were incorrect; in detail and in descending order these are 244/3889 (5.8%) for irregular antibodies, followed by Rh (215/13,528, 1.6%), cross-match (30/3285, 0.9%), DAT (11/1682, 0.6%), ABO (65/13,701, 0.5%), antibody screening (34/13,779, 0.2%) and Kell (5/2774, 0.2%). Tables 1 and 2 . Comparison of error rates of participants with quality systems certified already before or established during observation period, and laboratories without quality systems during the entire observation period is shown in Figure 1 . The more to the right a line is positioned, the higher the rate of incorrect results per laboratory. The lower the intercept with the vertical axis, the lower the number of laboratories without incorrect results; no incorrect results were submitted by 17.6% of laboratories that did not have ISO 9001/ISO 15189 quality system and by 39.4% of laboratories that maintained ISO quality systems during entire study period; 26.3% of laboratories that underwent ISO 9001 certification/ISO 15189 accreditation during study period. Due to low numbers of laboratories accredited according to ISO 15189, only a trend towards further reduction of error rates is recognisable considering ISO 9001 certification vs. ISO 15189 accreditation (0.7% vs. 0.5% incorrect results, p = 0.7883, data not shown).
A clear reduction of the rate of incorrect results was seen after ISO 9001 certification and ISO 15189 accreditation. In the 11,998 results of 38 laboratories that established quality systems during the observation period, differences in the rates of incorrect results before and after certification/accreditation were found for overall results (1.2% vs. 0.7%, p = 0.0468), for ABO (0.6% vs. 0.4%, p = 0.5051), for Rh (1.8% vs. 0.5%, p = 0.0016), antibody screening (0.1% Table 1 : Absolute values and percentages of incorrect results for all, ABO, Rh, and Kell depending on quality system status at the time of testing. Odds ratio and p-value are not shown for comparisons with zero incorrect results. Significant differences (p < 0.05) are for Rh phenotyping between hospital laboratories and independent laboratories (p = 0.0485), between independent laboratories and transfusion services (p = 0.016), and between transfusion services and hospital laboratories (p = 0.0001). Table 2 : Absolute values and percentages of incorrect results for DAT, antibody screening, antibody detection, and cross-match depending on quality system status at the time of testing. Odds ratio and p-value are not shown for comparisons with zero incorrect results. Significant differences (p < 0.05) are for antibody identification between independent laboratories and transfusion services (p = 0.0031) and between transfusion services and hospital laboratories (p = 0.0001).
DAT
vs. 0.2%, p = 0.3974) and for antibody identification (6.1% vs. 4.8%, p = 0.5137). Details are shown in Table 3 . Rates of incorrect results prior to certification/accreditation were comparable to those obtained by laboratories without quality systems (1.3% vs. 1.4%, data not shown). The laboratory type had an impact on performance of participants. As shown in Tables 1 and 2 , there are no significant differences between hospital and independent laboratories (both submitting 1.2% incorrect results, p = 0.985), whereas the lowest error rates were found in transfusion services (0.9%). The latter was statistically significant compared to hospital laboratories (p = 0.013) but not to independent laboratories (p = 0.0622). Significant differences were found for the rates of incorrect results for Rh between hospital laboratories (170/8734, 1.9%) and independent laboratories (33/2535, 1.3%; p = 0.0485), between independent laboratories and transfusion services (12/2259, 0.5%; p = 0.016), and between transfusion services and hospital laboratories (p = 0.0001); for antibody identification, significant differences were found between independent laboratories (49/749, 6.1%) and transfusion services (63/1637, 3.7%; p = 0.0031) and between transfusion services and hospital laboratories (132/1503, 8.1%; p = 0.0001). Even within the different types of laboratories a better performance can be seen when a laboratory maintains a quality system according to ISO 9001 or ISO 15189: Without certified/accredited quality systems transfusion services showed an overall rate of 1.2% incorrect results, hospital laboratories showed 1.3% and independent laboratories showed 2.3%; when there a certified/ accredited quality system, transfusion services showed a rate of 0.6% incorrect results, hospital laboratories 0.8%, and independent laboratories 0.7%. This observation not only applies to the overall performance, but also more or less clearly for most individual analytes. Corresponding results are shown in Tables 1 and 2 . While 39.4% (15/38) of laboratories with ISO 9001 certification since the beginning of the observation period did not submit even one single incorrect result, it was 17.6% (16/91) for laboratories that never had certification/ accreditation. Percentages of repetitive errors, that is more than one incorrect result for the same analyte, is 0.11% for laboratories with, and 0.34% for laboratories without aertified/accredited quality system during the entire observation period. Both groups examined a nearly identical portfolio of analytes (data not shown).
We detected 21 cases of possible sample swaps during the observation period; 14 affectted ABO results, five Rh and two affected a antibody-screening. In two cases ABO and Rh phenotyping were incorrect in the same distribution; the remaining cases affected only one analyte.
Discussion
Error rates in immunohaematology proficiency tests have been previously published and vary widely [22] [23] [24] . The overall performance of our participants is comparable to those earlier results.
Our evaluation shows that laboratories certified according to ISO 9001 or accredited according to ISO 15189 present significantly lower error rates than laboratories not maintaining such quality systems.
Results submitted by laboratories that underwent ISO certification and/or accreditation during the observation period allow for a direct comparison of performance before and after implementation of a quality system. In these cases, the positive effect of a quality system is particularly evident (except one outlier in the identification of irregular antibodies in laboratories accredited according to ISO 15189), as the rate of incorrect results has been significantly reduced while before certification/accreditation results are very comparable to those of laboratories without certified/accredited quality systems. This refutes arguments of causality reversal: it is evident that laboratory performance improves after implementation of a quality system, but not that mainly laboratories with already good performance decide to introduce quality systems.
Of course, the absence of a quality system does not exclude the possibility of excellence, as evidenced by the results of those 16 laboratories that did not submit a single incorrect result during their entire participations period without operating a quality system (data not shown). However, the use of an error management system as required by ISO 9001 and ISO 15189 is reflected in the lower rate of recurrence errors in laboratories that maintain certified/accredited quality systems.
As expected, specialisation in immunohaematology analyses has a positive impact on laboratory performance. While hospital laboratories and independent laboratories show about the same overall performance in our data, transfusion services have significantly lower error rates. We attribute this to the higher competence through specialisation on the one hand, and on the other hand, to regular official inspections in which competence management and corrective and preventive measures are monitored, albeit not specifically focussed on immunohaematology.
EQA schemes are designed to assess analytical performance, but are unable to assess procedural performance, as handling may differ between routine and EQA samples. Sample swaps are procedural errors, not analytical errors, but this does not affect the severity of the error. The 21 possible sample swaps in this evaluation had to be assessed accordingly.
In summary, it can be stated that a higher level of specialisation, such as in transfusion services, can be expected to result in a better performance at least in immunohaematology EQA participation.
According to our results, obligatory legal requirements and expert associations' guidelines are insufficient to ensure EQA results to an actually achievable extent. In contrast, quality systems according to ISO 9001 and ISO 15189 give a solid basis for higher analytical laboratory performance. Considering the extent of quality improvement and the increased patient safety shown here, time or effort should not be reasons not to implement such quality systems.
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